Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Lorenzi

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
The International Journal of Biochemistry & Cell Biology|February 26, 2008
Synthetic actin-binding domains reveal compositional constraints for functionMaria Lorenzi, Mario Gimona
Pediatric Blood & Cancer|December 21, 2013
Antidepressant use among survivors of childhood, adolescent, and young adult cancer: letter to the editor responseRebecca J Deyell, Maria Lorenzi, John J Spinelli, et al.
Plos One|February 7, 2018
Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetesÅsa Ericsson, Divina Glah, Maria Lorenzi, et al.
Future Oncology (London, England)|March 30, 2021
Systematic literature review for the association of biomarkers with efficacy of anti-PD-1 inhibitors in advanced melanomaEmilie Scherrer, Reina Rau, Maria Lorenzi, et al.
Biogerontology|March 18, 2018
A review of telomere length in sarcopenia and frailtyMaria Lorenzi, Stefano Bonassi, Teresa Lorenzi, et al.
Current Medical Research and Opinion|July 8, 2021
Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1Matthias Bischof, Maria Lorenzi, Jennifer Lee, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 21, 2016
Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-AnalysisMaria Lorenzi, Uffe Jon Ploug, Jakob Langer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 11, 2018
Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacyMaria Lorenzi, Baishali Ambegaonkar, Carl A Baxter, et al.
Lifetime Data Analysis|August 24, 2010
Analysis of recurrent events with non-negligible event duration, with application to assessing hospital utilizationX Joan Hu, Maria Lorenzi, John J Spinelli, et al.
Journal of Drug Assessment|September 7, 2019
An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanomaMaria Lorenzi, Stella Arndorfer, Raquel Aguiar-Ibañez, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
The International Journal of Biochemistry & Cell Biology|February 26, 2008
Synthetic actin-binding domains reveal compositional constraints for functionMaria Lorenzi, Mario Gimona
Pediatric Blood & Cancer|December 21, 2013
Antidepressant use among survivors of childhood, adolescent, and young adult cancer: letter to the editor responseRebecca J Deyell, Maria Lorenzi, John J Spinelli, et al.
Plos One|February 7, 2018
Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetesÅsa Ericsson, Divina Glah, Maria Lorenzi, et al.
Future Oncology (London, England)|March 30, 2021
Systematic literature review for the association of biomarkers with efficacy of anti-PD-1 inhibitors in advanced melanomaEmilie Scherrer, Reina Rau, Maria Lorenzi, et al.
Biogerontology|March 18, 2018
A review of telomere length in sarcopenia and frailtyMaria Lorenzi, Stefano Bonassi, Teresa Lorenzi, et al.
Current Medical Research and Opinion|July 8, 2021
Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1Matthias Bischof, Maria Lorenzi, Jennifer Lee, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 21, 2016
Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-AnalysisMaria Lorenzi, Uffe Jon Ploug, Jakob Langer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 11, 2018
Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacyMaria Lorenzi, Baishali Ambegaonkar, Carl A Baxter, et al.
Lifetime Data Analysis|August 24, 2010
Analysis of recurrent events with non-negligible event duration, with application to assessing hospital utilizationX Joan Hu, Maria Lorenzi, John J Spinelli, et al.
Journal of Drug Assessment|September 7, 2019
An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanomaMaria Lorenzi, Stella Arndorfer, Raquel Aguiar-Ibañez, et al.
Pageof 6